SCHEMBL29354516

SCHEMBL29354516

COCCOc1cc2c(N3CCC(C(C)CN)CC3)ccnc2cc1OC

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 7/20 0.55
EHMT1 Q9H9B1 7/20 0.55
NCF1 P14598 1/20 0.52
PDPK1 O15530 2/20 0.46
FLT3 P36888 2/20 0.45
PDGFRB P09619 2/20 0.41
CSF1R P07333 1/20 0.41
KIT P10721 1/20 0.41
ENPP1 P22413 1/20 0.41
FGFR1 P11362 1/20 0.41
FLT1 P17948 1/20 0.41
KDR P35968 1/20 0.41
NSD2 O96028 1/20 0.40
KDM1A O60341 2/20 0.40
PDE3A Q14432 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22441473 1.00 EHMT2 (0.55) EHMT2EHMT1NCF1PDPK1FLT3
SCHEMBL22445583 1.00 EHMT2 (0.55) EHMT2EHMT1NCF1PDPK1FLT3
SCHEMBL22441558 0.93 NCF1 (0.59) EHMT2EHMT1NCF1FLT3PDGFRB
SCHEMBL22445487 0.93 NCF1 (0.59) EHMT2EHMT1NCF1FLT3PDGFRB
SCHEMBL22445589 0.91 NCF1 (0.53) EHMT2EHMT1NCF1FLT3PDGFRB
SCHEMBL22441468 0.91 NCF1 (0.53) EHMT2EHMT1NCF1FLT3PDGFRB
SCHEMBL29354543 0.91 NCF1 (0.53) EHMT2EHMT1NCF1FLT3PDGFRB
SCHEMBL22445652 0.90 EHMT2 (0.59) EHMT2EHMT1NCF1PDPK1FLT3
SCHEMBL22455175 0.86 EHMT2 (0.49) EHMT2EHMT1NCF1PDPK1FLT3
SCHEMBL22441477 0.86 EHMT2 (0.54) EHMT2EHMT1NCF1PDPK1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113924092-B Quinoline and quinazoline compounds and methods of use thereof 斯汀格瑞治疗股份有限公司 2025-03-18 CN disclosed
EP-3941459-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF Stingray Therapeutics, Inc. (US) 2022-01-26 EP disclosed